Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...

Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.